Related Experiment Video
Updated: May 12, 2026
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
Novel IgM-based lateral flow assay for diagnosis of congenital Chagas disease
Luz M Peverengo1,2, Leandro E Peretti1,3,4, Maria B Warszatska5
1Laboratorio de Tecnología Inmunológica, Facultad de Bioquímica y Ciencias Biológicas (FBCB), Universidad Nacional del Litoral (UNL), Santa Fe, Argentina.
Background:
The diagnosis of congenital Chagas disease in newborns relies on the microhematocrit method which exhibits reduced sensitivity during the early stages of infection and quantitative PCR for Trypanosoma cruzi, which is applied only in specialised centre due to its technical complexity. Consequently, the majority of congenital transmission cases are confirmed after an extended period of serological monitoring, resulting in delayed treatments and reduced cure rates. The need for new, accurate tests for the timely diagnosis of the disease in newborns is evident.
Objectives:
We developed a lateral flow assay based on IgM detection (IgM-LFA) using the novel chimeric antigen CP4, which have demonstrated high performance in IgM-ELISA, as previously reported by our group.
Methods:
The accuracy of IgM-LFA was evaluated comparatively with IgM-ELISA using 28 serum samples from infants up to three months old, congenitally infected (n = 11) or non-infected (n = 17) with T. cruzi. Additionally, it was assessed for its agreement with microhematocrit and quantitative PCR, through estimating the Cohen's Kappa coefficient (k).
Results:
The IgM-LFA showed 100% specificity and 81.82% sensitivity and IgM-ELISA gave 100% specificity and sensitivity when evaluated against the standard algorithm diagnosis for congenital Chagas disease. Notably, the IgM-LFA identified two additional cases in relation to microhematocrit and showed a correlation of k = 0.84 with quantitative PCR, corresponding to almost perfect agreement with this molecular test.
Conclusion:
These results suggest that IgM-LFA has the potential to facilitate decentralised detection of congenital Chagas disease, contributing to the early and enhance detection of infected newborns.
